Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

(2017) Alexander W. MacFarlane et al.   OncoImmunology

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

(2015) Y. Shi et al.   ANNALS OF ONCOLOGY

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) B. Eichhorst et al.   ANNALS OF ONCOLOGY

Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease

(2014) Leticia Huergo-Zapico et al.   PLoS One

HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism

(2013) R. Rizzo et al.   HAEMATOLOGICA

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

(2013) R. Foa et al.   HAEMATOLOGICA

Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients

(2013) Paulina Własiuk et al.   HUMAN IMMUNOLOGY

Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy

(2013) E. Laprevotte et al.   JOURNAL OF IMMUNOLOGY

Location and cellular stages of natural killer cell development

(2013) Jianhua Yu et al.   TRENDS IN IMMUNOLOGY

Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy

(2012) Caroline Veuillen et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

(2011) Zhi-Qiang Ning et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia

(2011) Régis T. Costello et al.   IMMUNOLOGY

Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer

(2011) Baocheng Huang et al.   JOURNAL OF IMMUNOTHERAPY

A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells

(2010) Lin Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia

(2010) Christine I. Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab: Mechanism of Action

(2010) George J. Weiner   SEMINARS IN HEMATOLOGY

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

(2008) A. Ferrajoli et al.   BLOOD

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

(2008) Shanique Palmer et al.   BRITISH JOURNAL OF HAEMATOLOGY

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

(2008) Christine Galustian et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia

(2008) Lijuan Chen et al.   LEUKEMIA RESEARCH

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia

(2008) Wei Xu et al.   LEUKEMIA RESEARCH

Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia

(2007) Wei Xu et al.   LEUKEMIA RESEARCH